Daridorexant for adults with attention deficit hyperactivity disorder (ADHD) and insomnia disorder: An exploratory study
Comprehensive Psychiatry · 2026-06 · 148 · 152700
DOI: 10.1016/j.comppsych.2026.152700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comprehensive Psychiatry, 2026-06. Verfasst von Giacomo Grassi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Brain Center Firenze, Florence, Italy. Electronic address: giacomograssimd@gmail.com. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Sleep Initiation and Maintenance Disorders, Pyrrolidines, Orexin Receptor Antagonists. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Idorsia Pharmaceuticals Ltd.
Themen: Schlaf
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain Center Firenze, Florence, Italy. Electronic address: giacomograssimd@gmail.com.
- Brain Center Firenze, Florence, Italy.
Förderung
- Idorsia Pharmaceuticals Ltd
Zitieren
APA
Grassi, G., Scillitani, E., Moradei, C., & Cecchelli, C. (2026). Daridorexant for adults with attention deficit hyperactivity disorder (ADHD) and insomnia disorder: An exploratory study. Comprehensive Psychiatry, 148, 152700. https://doi.org/10.1016/j.comppsych.2026.152700
Vancouver
Grassi G, Scillitani E, Moradei C, Cecchelli C. Daridorexant for adults with attention deficit hyperactivity disorder (ADHD) and insomnia disorder: An exploratory study. Comprehensive Psychiatry. 2026;148:152700. doi:10.1016/j.comppsych.2026.152700
BibTeX
@article{Grassi2026,
author = {Grassi, Giacomo and Scillitani, Edoardo and Moradei, Corinna and Cecchelli, Chiara},
title = {Daridorexant for adults with attention deficit hyperactivity disorder (ADHD) and insomnia disorder: An exploratory study},
journal = {Comprehensive Psychiatry},
year = {2026},
volume = {148},
pages = {152700},
doi = {10.1016/j.comppsych.2026.152700}
}
EUVIMED